CTRI/2020/05/025340
Completed
Phase 1
Clinical trial to evaluate the safety and efficacy of ShatPlus an Ayurvedic Proprietary Medicine as an intervention in adult patients with SARS-CoV-2 infection.
BVG Life Sciences Ltd BVG Group0 sites60 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Sponsor
- BVG Life Sciences Ltd BVG Group
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •SARS\-CoV\-2 positive nasopharyngeal swab
- •Mild to Moderately severe disease (NEWS score \<\= 8\)
- •Signed informed consent must be obtained and documented according to AYUSH GCP, and national/local regulations
Exclusion Criteria
- •Requiring ICU admission at screening
- •History of MI, Epileptic episodes
- •Any other comorbidity which is at critical stage at screening
- •Any other condition by which subject proves unfit from investigator perspective
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Not Applicable
Clinical trial to evaluate the safety and efficacy of synthetic bone graft substitutes with growth factors for posterior lumbar interbody fusioKCT0004738The Catholic University of Korea, Seoul St. Mary's Hospital20
Active, not recruiting
Not Applicable
Evaluation the safety and efficacy for gastrocnemius hypertrophy of Botox injectioKCT0008039Asan Medical Center20
Completed
Not Applicable
Clinical trial to evaluate the safety and efficacy of cinnamon extracts on the improvement of bowel function and microfloraDiseases of the digestive systemKCT0003399Semyung University Oriental Medicine Hospital70
Completed
Not Applicable
Clinical trial to evaluate the safety and efficacy for improvement trapezius hypertrophy of botulax® injection.Factors influencing health status and contact with health servicesKCT0009443Asan Medical Center20
Not yet recruiting
Not Applicable
Clinical trial to evaluate the efficacy and safety of massage using a CMP-100 medical device in patients with shoulder-back myofascial pain syndromKCT0003971Wonkwang University, Gwangju Medical Center40